JINYU(SH:600201) 梧桐树下V·2025-07-28 10:47Core Viewpoint - The article discusses the regulatory actions taken by the Inner Mongolia Securities Regulatory Bureau against the accounting firm Zhihong and its signing accountants for inadequate audit procedures related to Jin Yu Biotechnology Co., Ltd.'s financial statements for 2023 [1][2]. Group 1: Audit Issues - The audit procedures for research and development expenses were inadequately executed, leading to incorrect capitalization timing for certain projects, and insufficient audit evidence was obtained [1][2]. - The audit procedures for long-term equity investments were also inadequately executed, particularly in the calculation of investment income from Guoyi Life Science Technology Co., Ltd. and Beijing Jiuyang Wisdom Investment Fund Management Co., Ltd., with insufficient audit evidence obtained [2]. Group 2: Regulatory Actions - The actions of the accountants violated the "Management Measures for Information Disclosure of Listed Companies," specifically Articles 45 and 46, leading to the issuance of a warning letter and recording in the securities and futures market integrity database [2][3]. - The accountants are required to submit a written report to the regulatory bureau within 30 days of receiving the decision and must adhere to relevant laws and auditing standards to improve audit quality [3].